NDC 81968-045 – Auvelity
Dextromethorphan Hydrobromide 45 mg/1; Bupropion Hydrochloride 105 mg/1 · Tablet, Multilayer, Extended Release · Oral
Product NDC81968-045
Product details
- Brand name
- Auvelity
- Generic name
- Dextromethorphan hydrobromide, bupropion hydrochloride
- Labeler
- Axsome Therapeutics, Inc.
- Dosage form
- Tablet, Multilayer, Extended Release
- Route
- Oral
- Marketing category
- NDA · NDA215430
- Marketed since
- August 18, 2022
- Listing expires
- December 31, 2027
- Pharmacologic class
- Aminoketone; Sigma-1 Agonist; Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Active ingredients
- Dextromethorphan Hydrobromide 45 mg/1
- Bupropion Hydrochloride 105 mg/1
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 81968-045-14 sample | 1 BOTTLE in 1 CARTON (81968-045-14) / 14 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE | Sep 18, 2024 |
| 81968-045-30 | 30 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (81968-045-30) | Aug 18, 2022 |
| 81968-045-31 sample | 1 BOTTLE in 1 CARTON (81968-045-31) / 30 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE | May 10, 2024 |
| 81968-045-60 | 60 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (81968-045-60) | Jun 28, 2024 |